| Pharmaceutical active ingredients: |
| Betamethasone DipropionateClotrimazole |
| Available forms, composition and doses of Flotiran: |
| N / A |
| Flotiran medical category: |
| Human:Anti-inflammatory agentsAzoles |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D01AC20 - Imidazole and Triazole derivatives, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Schering-Plough |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Clotrimazole; Betamethasone | Betamethasone Dipropionate; Clotrimazole | Taro Pharmaceutical Industries |
| Clotrimin-B | Betamethasone Dipropionate; Clotrimazole | Medipharm, Chile |
| Clotrisone | Betamethasone Dipropionate; Clotrimazole | Taro Pharmaceutical Industries |
| Cortispec | Betamethasone Dipropionate; Clotrimazole | Euroderm Laboratorios |
| Creminem-B | Betamethasone Dipropionate; Clotrimazole | Mintlab |
| Locrim | Betamethasone Dipropionate; Clotrimazole | Pharma Investi de Chile |
| Lotricomb | Betamethasone Dipropionate; Clotrimazole | Schering-Plough; Essex |
| Lotriderm | Betamethasone Dipropionate; Clotrimazole | Schering-Plough; Bayer Schering Pharma; Fulford Pharmaceuticals; Merck; Pliva; United Drug |
| Lotrisone | Betamethasone Dipropionate; Clotrimazole | Schering-Plough; Bayer Schering Pharma |
| Micomazol B | Betamethasone Dipropionate; Clotrimazole | ICN Pharmaceuticals |